MIRA Pharmaceuticals (MIRA) vs NextCure (NXTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
NextCure (NXTC) has outperformed MIRA Pharmaceuticals (MIRA) over the past year, gaining 10.0% versus a loss of 44.4%. NextCure is the larger company by market cap ($32.9 million vs $31.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MIRA | NXTC |
|---|---|---|
| Share price | $0.7455 | $7.18 |
| Market cap | $31.33M | $32.87M |
| 1-day change | +6.05% | +5.90% |
| YTD return | -50.63% | -49.40% |
| 1-year return | -44.37% | +9.95% |
| 5-year return | — | -93.15% |
| EPS (TTM) | $-1.21 | $-8.90 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.45 | $15.74 |
| 52-week low | $0.60 | $1.55 |
| Distance from 52-week high | -69.57% | -54.38% |
| Analyst consensus | none | none |
| Avg. price target upside | +369.48% | +178.55% |
| Average volume | 585.75K | 2.11M |
| Shares outstanding | 42.02M | 4.58M |
| Employees | — | 40 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NXTC has outperformed MIRA by 54.3 percentage points over the past year.
About MIRA Pharmaceuticals
MIRA stock →MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
Health Care · Biotechnology: Pharmaceutical Preparations
About NextCure
NXTC stock →NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors.
Health Care · Biotechnology: Pharmaceutical Preparations · 40 employees
MIRA vs NXTC FAQ
Which is bigger, MIRA Pharmaceuticals or NextCure?
NextCure (NXTC) is larger, with a market capitalization of $32.87M compared with $31.33M for MIRA Pharmaceuticals (MIRA).
Which stock has performed better over the past year, MIRA or NXTC?
NXTC returned +9.95% over the past 12 months, compared with -44.37% for MIRA (price return, excluding dividends). Past performance does not predict future results.
Are MIRA Pharmaceuticals and NextCure in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.